Pituitary incidentaloma

Czech version

Authors: Michal Kršek
Authors‘ workplace: 3. interní klinika – klinika endokrinologie a metabolismu, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha
Published in: Vnitř Lék 2022; 68(2): 127-130
Category: In Brief

Overview

Pituitary incidentaloma are being accidentally found during imaging procedures in approximately 10% of normal population. Facing pituitary incidentalomas endocrinologists have to decide about further management based on the assessment of hormonal activity, aetiology, size, and possible compressive symptoms. Treatment of choice for prolactinomas is medical therapy. Surgical treatment is a treatment of choice for other hormonally active tumours and in case of complications as defects of visual field, pituitary apoplexy with compressive symptoms, ophthalmoplegia respectively. Tumour not indicated for surgical treatment are followed-up by imaging techniques and in indicated cases also by endocrinological or visual field evaluation.

Keywords:

diagnosis – therapy – incidentaloma – pituitary – follow‑up – tumours

Sources

1. Sano N, Oyama K, Tahara S et al. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 2003;149:123-127.

2. Fainstein Day P, Guitelman M, Artese R et al. Retrospective multicentric study of pituitary incidentalomas. Piuitary 2004;7:145-148.

3. Freda PU, Beckers AM, Katznelson L et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(4):894-904.

4. Molitch ME. Pituitary tumours: pituitary incidentalomas. Best Practice & Research: Clinical Endocrinology & Metabolism 2009;23:667-675.

5. Lania A, Beck‑Peccoz P. Pituitary incidentalomas. Best Practice & Research: Clinical Endocrinology & Metabolism 2012;26:395-403.

6. Vasilev V, Rostomyan L, Daly AF et al. Pituitary „incidentaloma“: neuroradiological assessment and differential diagnosis. Eur J Endocrinol 2016;175(4):R171-R184.

7. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 1999;28:81-117.

8. Melmed S. Evaluation of pituitary masses. In: DeGroot LJ, Jameson JL (eds.) Endocrinology. 5th Edition, 2006, Elsevier Saunders: Philadelphia, USA 2006:387-395. ISBN: 978-9997636768.

Labels

Diabetology Endocrinology Internal medicine

Editorial

Prediabetes

ADA Standards of Medical Care in Diabetes 2022 – what’s new?

Oral semaglutide – Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice

The position of SGLT2 inhibitors in current medical practice – update 2022

What do the new ESC Guidelines for the treatment of heart failure bring to internists?

Anticoagulation in cancer patients; new recommendations based on randomized clinical trials

Colorectal cancer in patients with diabetes – epidemiology, pathophysiology and applications for clinical practice

Any expectations from the more powerful dulaglutide?

Pharmacological possibilities of vitamin C in oncology

Article was published in

Internal Medicine

2022 Issue 2